The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday

The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday

While the overall survival of patients with castration-resistant prostate cancer (CRPC) has been prolonged by enzalutamide, a considerable number of patients suffer from enzalutamide-induced nausea and fatigue. An 86-year-old male patient who started enzalutamide (160 mg) for CRPC treatment, experie...

Full description

Bibliographic Details
Main Authors: Takashi Kawahara, Yasuhide Miyoshi, Masahiro Yao, Hiroji Uemura
Format: Article
Language:English
Published: Karger Publishers 2019-07-01
Series:Case Reports in Oncology
Subjects:
Enzalutamid
Xtandi
Drug holiday
Online Access:https://www.karger.com/Article/FullText/501849

Similar Items

Similar Items